166 related articles for article (PubMed ID: 31212060)
21. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test.
Madiha S; Haider S
Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334
[TBL] [Abstract][Full Text] [Related]
22. Partial lesion of the dopaminergic innervation of the ventral striatum induces "depressive-like" behavior of rats.
Kuter K; Kolasiewicz W; Gołembiowska K; Dziubina A; Schulze G; Berghauzen K; Wardas J; Ossowska K
Pharmacol Rep; 2011; 63(6):1383-92. PubMed ID: 22358086
[TBL] [Abstract][Full Text] [Related]
23. Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats.
Chen L; Liu J; Zhang QJ; Feng JJ; Gui ZH; Ali U; Wang Y; Fan LL; Hou C; Wang T
Brain Res Bull; 2011 Jul; 85(6):329-38. PubMed ID: 21624440
[TBL] [Abstract][Full Text] [Related]
24. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
25. Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats.
Silva TP; Poli A; Hara DB; Takahashi RN
Neurosci Lett; 2016 May; 622():83-7. PubMed ID: 27113204
[TBL] [Abstract][Full Text] [Related]
26. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model.
Fatemi I; Abdollahi A; Shamsizadeh A; Allahtavakoli M; Roohbakhsh A
Acta Neuropsychiatr; 2021 Feb; 33(1):15-21. PubMed ID: 32967746
[TBL] [Abstract][Full Text] [Related]
27. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
28. Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.
Rampersaud N; Harkavyi A; Giordano G; Lever R; Whitton J; Whitton PS
Neuropeptides; 2012 Oct; 46(5):183-93. PubMed ID: 22921965
[TBL] [Abstract][Full Text] [Related]
29. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
[TBL] [Abstract][Full Text] [Related]
30. Depressive-like neurochemical and behavioral markers of Parkinson's disease after 6-OHDA administered unilaterally to the rat medial forebrain bundle.
Kamińska K; Lenda T; Konieczny J; Czarnecka A; Lorenc-Koci E
Pharmacol Rep; 2017 Oct; 69(5):985-994. PubMed ID: 28843848
[TBL] [Abstract][Full Text] [Related]
31. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
33. Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.
Vecchia DD; Kanazawa LKS; Wendler E; Hocayen PAS; Vital MABF; Takahashi RN; Da Cunha C; Miyoshi E; Andreatini R
Brain Res Bull; 2021 Mar; 168():63-73. PubMed ID: 33359641
[TBL] [Abstract][Full Text] [Related]
34. The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.
Santiago RM; Tonin FS; Barbiero J; Zaminelli T; Boschen SL; Andreatini R; Da Cunha C; Lima MM; Vital MA
Neuroscience; 2015 Aug; 300():246-53. PubMed ID: 25999296
[TBL] [Abstract][Full Text] [Related]
35. The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.
Schamne MG; Mack JM; Moretti M; Matheus FC; Walz R; Lanfumey L; Prediger RD
Neurotox Res; 2018 Nov; 34(4):808-819. PubMed ID: 29808370
[TBL] [Abstract][Full Text] [Related]
36. Temporal development of behavioral impairments in rats following locus coeruleus lesion induced by 6-hydroxydopamine: Involvement of β
Sampaio TB; Soares de Souza B; Roversi K; Schuh T; Poli A; Takahashi RN; Prediger RD
Neuropharmacology; 2019 Jun; 151():98-111. PubMed ID: 30959019
[TBL] [Abstract][Full Text] [Related]
37. High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat.
He Z; Jiang Y; Xu H; Jiang H; Jia W; Sun P; Xie J
Behav Brain Res; 2014 Apr; 263():108-14. PubMed ID: 24462728
[TBL] [Abstract][Full Text] [Related]
38. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
[TBL] [Abstract][Full Text] [Related]
39. Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease.
Chen HH; Chang PC; Chen C; Chan MH
Pharmacol Rep; 2018 Aug; 70(4):668-676. PubMed ID: 29909247
[TBL] [Abstract][Full Text] [Related]
40. Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat.
Amalric M; Moukhles H; Nieoullon A; Daszuta A
Eur J Neurosci; 1995 May; 7(5):972-80. PubMed ID: 7613632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
